S100A8/S100A9-INDUCED IMMUNOTOLERANCE IN NEWBORN SUBJECTS

• 收藏
• 分享

专利权人:

Medizinische Hochschule Hannover (MHH);Westfälische Wilhelms-UniversitätMünster

发明人:

Dorothee Viemann,Johannes Roth,Thomas Vogl

申请号：

US16347907

公开号：

US20190374605A1

申请日:

2017.11.06

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present application provides for the use of S100A8 or S100A9 homodimer or S100A8/A9 heterodimer in the prevention or treatment of a NF-κB-associated postnatal inflammatory disorder in a newborn subject. Moreover, the present invention relates to a pharmaceutical composition comprising S100A8 or S100A9 homodimer or S100A8/A9 heterodimer and an in vitro method for evaluating the risk of a newborn subjectfor developing a NF-κB-associated postnatal inflammatory disorder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/